Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
macrophage stimulating 1 pseudogene 2 (MST1P2) is classified as a pseudogene, meaning it is an inactive segment of DNA that is similar to a functional gene but does not encode a functional protein. It is related to the functional macrophage stimulating 1 (MST1) gene, which codes for the cytokine MSP, but MST1P2 does not encode a protein product and has no known biological or disease function as a protein, receptor, or therapeutic target[1][4][7][8][14]. MST1P2 is not an active protein or receptor, but a pseudogene, meaning the information does not pertain to a therapeutic target. The related active protein is MSP, encoded by MST1, which is a cytokine involved in macrophage signaling[6][12]. There are no drugs, mechanisms of action, or known biomarker or safety issues associated with the pseudogene MST1P2[4][14]. Claims found in some databases that MST1P2 might play a regulatory RNA role (as in cancer progression via sponging microRNA) are not equivalent to it being a classic protein therapeutic target or receptor[8]. If you are seeking information about the functional target in the macrophage stimulating protein pathway, you should look for macrophage stimulating 1 (MST1) or macrophage stimulating 1 receptor (MST1R, also known as RON), not MST1P2[11][12][13]. Summary statement: MST1P2 is a pseudogene, not a receptor or enzyme, with no established role as a therapeutic target[4][7][14]. Any apparent confusion with the actual targetable protein (MSP, MST1) should be clarified for downstream structured data collection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on macrophage stimulating 1 pseudogene 2 (MST1P2).